What is Nym Health?
Nym Health operates at the intersection of clinical expertise and artificial intelligence, specializing in the transformation of complex medical charts into accurate, compliant, and explainable information. By decoding clinical language, the platform removes significant administrative friction that contributes to the rising costs of global healthcare. Nym's technology is designed to be highly scalable, providing healthcare providers and payers with a robust toolset to streamline revenue cycle management and improve operational transparency. Its market position is defined by its commitment to explainability, ensuring that automated medical coding remains auditable and reliable in highly regulated environments.
How much funding has Nym Health raised?
Nym Health has raised a total of $94.5M across 4 funding rounds:
Angel/Seed
$6M
Series A
$16.5M
Unspecified
$25M
Private Equity
$47M
Angel/Seed (2019): $6M with participation from Bessemer Venture Partners
Series A (2020): $16.5M led by Lightspeed, GV, Nat Turner, Bessemer Venture Partners, Zach Weinberg, Dynamic Loop Capital, Flatiron Health, and Tiger Global
Unspecified (2021): $25M supported by Addition
Private Equity (2024): $47M featuring Samsung NEXT, Addition, PSG, and Dynamic Loop Capital
Key Investors in Nym Health
Samsung NEXT
A strategic investment arm that provides software and services to complement global hardware ecosystems, focusing on product development and M&A.
Addition
A global venture capital firm dedicated to supporting founder-led, technology-enabled companies in their early and growth stages.
Bessemer Venture Partners
A long-standing venture capital firm with a global presence, known for its extensive history in backing transformative technology and enterprise software companies.
What's next for Nym Health?
With the successful closure of its latest financing round, Nym Health is well-positioned to scale its enterprise operations and expand its footprint in the healthtech ecosystem. The strategic focus will likely center on deepening its integration capabilities within existing electronic health record systems and broadening its clinical language processing models to cover additional medical specialties. As the demand for automated, high-accuracy medical coding continues to rise, Nym is poised to leverage its recent capital injection to maintain its competitive edge, potentially exploring new market segments where clinical data interpretation is critical for operational efficiency and cost containment.
See full Nym Health company page
